Literature DB >> 15176833

A stereochemical surprise at the late stage of the synthesis of fully N-differentiated heparin oligosaccharides containing amino, acetamido, and N-sulfonate groups.

Gregory J S Lohman1, Peter H Seeberger.   

Abstract

The glucosamine residues in heparin-like glycosaminoglycans have been found to exist as amines, acetamides, and N-sulfonates. To develop a completely general, modular synthesis of heparin, three degrees of orthogonal nitrogen protection are required. Reported herein is a strategy for the synthesis of fully N-differentiated heparin oligosaccharides in the context of target octasaccharide 1, which contains an N-acetate, N-sulfonates, and a free amine. The protecting group scheme used in the synthesis blocked the N-acetate as a N-diacetate, the N-sulfonates as azido groups, and the amine as a N-CBz; free hydroxyls were masked as benzyl ethers and O-sulfonates as acetate esters. Disaccharide and tetrasaccharide modules were synthesized using this strategy; however, the union of tetrasaccharide trichloroacetimidate 4 with disaccharide acceptor 5 unexpectedly formed the undesired beta-linked glycoside in addition to the alpha-linkage anticipated for iduronic acid nucleophiles, resulting in an inseparable 6:1 alpha/beta mixture of products. Detailed studies into the basis for this unexpected result were conducted and are also reported.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15176833     DOI: 10.1021/jo035732z

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  15 in total

Review 1.  Controlled microwave heating in modern organic synthesis: highlights from the 2004-2008 literature.

Authors:  C Oliver Kappe; Doris Dallinger
Journal:  Mol Divers       Date:  2009-04-21       Impact factor: 2.943

Review 2.  The chemical neurobiology of carbohydrates.

Authors:  Heather E Murrey; Linda C Hsieh-Wilson
Journal:  Chem Rev       Date:  2008-05-02       Impact factor: 60.622

3.  Preactivation-based, one-pot combinatorial synthesis of heparin-like hexasaccharides for the analysis of heparin-protein interactions.

Authors:  Zhen Wang; Yongmei Xu; Bo Yang; Gopinath Tiruchinapally; Bin Sun; Renpeng Liu; Steven Dulaney; Jian Liu; Xuefei Huang
Journal:  Chemistry       Date:  2010-07-26       Impact factor: 5.236

Review 4.  Synthetic Oligosaccharide Libraries and Microarray Technology: A Powerful Combination for the Success of Current Glycosaminoglycan Interactomics.

Authors:  Vitor H Pomin; Xu Wang
Journal:  ChemMedChem       Date:  2017-12-06       Impact factor: 3.466

5.  Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction.

Authors:  Yu-Peng Hu; Shu-Yi Lin; Cheng-Yen Huang; Medel Manuel L Zulueta; Jing-Yuan Liu; Wen Chang; Shang-Cheng Hung
Journal:  Nat Chem       Date:  2011-06-19       Impact factor: 24.427

6.  Pre-activation based stereoselective glycosylations: Stereochemical control by additives and solvent.

Authors:  Wasonga Gilbert; Zeng Youlin; Huang Xuefei
Journal:  Sci China Chem       Date:  2011-01-01       Impact factor: 9.445

7.  Divergent heparin oligosaccharide synthesis with preinstalled sulfate esters.

Authors:  Gopinath Tiruchinapally; Zhaojun Yin; Mohammad El-Dakdouki; Zhen Wang; Xuefei Huang
Journal:  Chemistry       Date:  2011-07-22       Impact factor: 5.236

8.  Stereoselective synthesis of the disaccharide unit of incednine.

Authors:  Jason R Abbott; William R Roush
Journal:  Org Lett       Date:  2012-12-18       Impact factor: 6.005

9.  Solid-phase synthesis of alpha-glucosamine sulfoforms with fragmentation analysis by tandem mass spectrometry.

Authors:  Runhui Liu; Chamnongsak Chanthamontri; Hongling Han; Jesús M Hernández-Torres; Karl V Wood; Scott A McLuckey; Alexander Wei
Journal:  J Org Chem       Date:  2008-07-09       Impact factor: 4.354

Review 10.  Enzymatic synthesis of glycosaminoglycan heparin.

Authors:  Robert J Linhardt; Jonathan S Dordick; Paul L Deangelis; Jian Liu
Journal:  Semin Thromb Hemost       Date:  2007-07       Impact factor: 4.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.